Package 68788-4018-1

{"route": ["ORAL"], "spl_id": "f9e9a953-2802-4bb1-91a3-a29be347801e", "openfda": {"nui": ["N0000175599", "N0000020026"], "unii": ["742SXX0ICT"], "rxcui": ["403957"], "spl_set_id": ["f9e9a953-2802-4bb1-91a3-a29be347801e"], "pharm_class_epc": ["Phosphodiesterase 5 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 5 Inhibitors [MoA]"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "15 TABLET in 1 BOTTLE (68788-4018-1)", "package_ndc": "68788-4018-1", "marketing_start_date": "20250829"}, {"sample": false, "description": "20 TABLET in 1 BOTTLE (68788-4018-2)", "package_ndc": "68788-4018-2", "marketing_start_date": "20250829"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (68788-4018-3)", "package_ndc": "68788-4018-3", "marketing_start_date": "20250829"}], "brand_name": "TADALAFIL", "product_id": "68788-4018_f9e9a953-2802-4bb1-91a3-a29be347801e", "dosage_form": "TABLET", "pharm_class": ["Phosphodiesterase 5 Inhibitor [EPC]", "Phosphodiesterase 5 Inhibitors [MoA]"], "product_ndc": "68788-4018", "generic_name": "TADALAFIL", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TADALAFIL", "active_ingredients": [{"name": "TADALAFIL", "strength": "5 mg/1"}], "application_number": "ANDA211839", "marketing_category": "ANDA", "marketing_start_date": "20250829", "listing_expiration_date": "20261231"}